Aldeyra Therapeutics (ALDX +18.8%) hires Stephen Tuilpano as its new CFO effective June 23, 2014. He joins the company from accounting and management advisory firm Three Tulips where he was a consultant. Prior to that, he was CFO at Javelin Pharmaceuticals.
Sent to 71 people who get email alerts on ALDX.
Get email alerts on ALDX »
Want to be faster and smarter on all your stocks?
Upgrade all your basic real-time alerts to PRO Alerts, for $20.